On March 19, the U.S. Food and Drug Administration (FDA) held its second public meeting to obtain input on the Patient-Focused Drug Development Guidance currently under development by the Agency. Evidera had representation from our Patient-Centered Research team in attendance to hear and contribute to the discussion. The topic of this meeting was specific to how external stakeholders can develop and submit proposed draft guidance relating to patient experience data to the Agency, and the meeting was attended by a wide variety of patient stakeholder groups. Key highlights and discussion points of interest from the meeting are noted below.